کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1360934 | 981452 | 2008 | 7 صفحه PDF | دانلود رایگان |

In this work we prepared and characterized an inclusion complex of the dihydropteroate synthase inhibitor sulfadiazine (SDZ) in 2-hydroxypropyl-β-cyclodextrin (HPBCD). From the phase-solubility diagram we observed an increase in the water solubility of the drug, calculating a binding constant of 1879 M−1. The inclusion mode involves a NH2-in orientation of the drug in the HPBCD cavity, according to the 2D NMR (ROESY) data and confirmed by molecular modeling using the semiempirical PM6 and RM1 methods.
A 1:1 inclusion complex of sulfadiazine with hydroxypropyl β-cyclodextrin was prepared, characterized and modeled by RM1 and PM6 semiempirical methods. Phase-solubility and characterization of the system were carried out by standard methods.Figure optionsDownload as PowerPoint slide
Journal: Bioorganic & Medicinal Chemistry - Volume 16, Issue 10, 15 May 2008, Pages 5788–5794